[HTML][HTML] Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management

B Singh, CM Day, S Abdella, S Garg - Journal of Controlled Release, 2024 - Elsevier
Abstract Alzheimer's disease (AD), is a neurodegenerative disorder that escalates with time,
exerting a significant impact on physical and mental health and leading to death. The …

[HTML][HTML] Amyloid β, lipid metabolism, basal cholinergic system, and therapeutics in Alzheimer's disease

V Campos-Peña, P Pichardo-Rojas… - International Journal of …, 2022 - mdpi.com
The presence of insoluble aggregates of amyloid β (Aβ) in the form of neuritic plaques (NPs)
is one of the main features that define Alzheimer's disease. Studies have suggested that the …

Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review

FE Pozzi, E Conti, I Appollonio, C Ferrarese… - Frontiers in …, 2022 - frontiersin.org
Background The mainstay of therapy for many neurodegenerative dementias still relies on
acetylcholinesterase inhibitors (AChEI); however, there is debate on various aspects of such …

The effects of different acetylcholinesterase inhibitors on EEG patterns in patients with Alzheimer's disease: A systematic review

S Arjmandi-Rad, JD Vestergaard Nieland… - Neurological …, 2024 - Springer
Objective Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the
most common type of dementia. The early diagnosis of AD is an important factor for the …

Structural and functional remodeling of neural networks in β-amyloid driven hippocampal hyperactivity

J Li, Y Liu, C Yin, Y Zeng, Y Mei - Ageing Research Reviews, 2024 - Elsevier
Early detection of Alzheimer's disease (AD) is essential for improving the patients outcomes
and advancing our understanding of disease, allowing for timely intervention and treatment …

Miracle fruit seed as a potential supplement for the treatment of learning and memory disorders in Alzheimer's disease

XY Huang, LL Xue, TB Chen, LR Huangfu… - Frontiers in …, 2023 - frontiersin.org
Currently, the treatment of Alzheimer's disease (AD) is still at the stage of symptomatic
treatment due to lack of effective drugs. The research on miracle fruit seeds (MFSs) has …

Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review

R Reddi Sree, M Kalyan, N Anand, S Mani… - ACS …, 2025 - ACS Publications
Alzheimer's disease (AD) is an aging-related irreversible neurodegenerative disease
affecting mostly the elderly population. The main pathological features of AD are the …

[HTML][HTML] Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review

RR Sree, M Kalyan, N Anand, S Mani… - ACS …, 2025 - pmc.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is an aging-related irreversible neurodegenerative disease
affecting mostly the elderly population. The main pathological features of AD are the …

[PDF][PDF] Treatment options for Alzheimer's Disease: An overview of the amyloid, tau, and alternate hypotheses

K Eroltu - Journal of High School Science, 2023 - jhss.scholasticahq.com
Alzheimer's disease (AD) tends to be more common in people sixty-five years of age and
over. AD is a progressive brain disease that affects memory, thinking, and behavior …

Investigating the Protective Effects of Phototherapy and various drugs in Alzheimer Disease

L Tanveer - 2024 - repositories.nust.edu.pk
Alzheimer's disease (AD) is a prevailing public health concern as it causes neuronal
degeneration resulting in cognitive impairment and memory loss with epidemiology of …